Evidence map›Paper›PMID 40732250›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Curcumin Derivative CU4c Exhibits HDAC-Inhibitory and Anticancer Activities Against Human Lung Cancer Cells In Vitro and in Mouse Xenograft Models.

Narissara Namwan, Gulsiri Senawong, Chanokbhorn Phaosiri, Pakit Kumboonma, La-Or Somsakeesit, Pitchakorn Sangchang, Thanaset Senawong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Narissara NamwanDepartment of Biochemistry, Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.
Gulsiri SenawongDepartment of Biochemistry, Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.
Chanokbhorn PhaosiriDepartment of Chemistry, Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.ORCID 0000-0002-0108-0204
Pakit KumboonmaDepartment of Applied Chemistry, Faculty of Science and Liberal Arts, Rajamangala University of Technology Isan, Nakhon Ratchasima 30000, Thailand.ORCID 0000-0002-4726-5191
La-Or SomsakeesitDepartment of Chemistry, Faculty of Engineering, Rajamangala University of Technology Isan, Khon Kaen 40000, Thailand.ORCID 0000-0003-2834-2304
Pitchakorn SangchangDepartment of Biochemistry, Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.
Thanaset SenawongDepartment of Biochemistry, Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.ORCID 0000-0001-8788-5291

Funding

Graduate School of Khon Kaen University 651T217National Science Research and Innovation Fund Fundamental Fund 2568
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apoptosiscell cycle arrestchemosensitizercisplatincurcumin derivative CU4cdrug combinationgemcitabineHDAC inhibitorlung cancer

Identifiers

PMID40732250
PMCPMC12297909

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.